IO Biotech, Inc. (IOBT) Financials

IOBT Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2025 40.0 million 39.0 million
June 30, 2025 42.3 million 40.7 million
March 31, 2025 45.7 million 19.3 million
Dec. 31, 2024 67.7 million 20.7 million

IOBT Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 -18.5 million 1.5 million
June 30, 2025 -19.8 million 1.6 million
March 31, 2025 -23.1 million 1.6 million
Dec. 31, 2024 -19.6 million 1.6 million

IOBT Net Income

No data available :(

IOBT Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 30.7 million 667000 1.5 million
June 30, 2025 28.1 million 6.7 million 868000
March 31, 2025 37.1 million - 1.8 million
Dec. 31, 2024 60.0 million - 1.9 million

IOBT Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2025 66.9 million
June 30, 2025 65.9 million
March 31, 2025 65.9 million
Dec. 31, 2024 65.9 million

IOBT Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 4000 13.7 million 5.4 million -
June 30, 2025 26000 16.7 million 6.3 million -
March 31, 2025 28000 16.4 million 6.0 million -
Dec. 31, 2024 11000 21.1 million 5.6 million -

IOBT Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 - 230000
June 30, 2025 - 234000
March 31, 2025 - 227000
Dec. 31, 2024 850000 219000

IOBT

Price: $0.05

52 week price:
0.00
2.79

Earnings Per Share: -0.23 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Denmark

Volume: 106527

Market Capitalization: 3.5 million

Links: